Loading insider details...
Latest Form 4 (Nov 18, 2026): Sale of 100,000 RPRX shares, $6.81M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 18, 2026 | Royalty Pharma plc (RPRX) | Sale | 100,000 | $6.81M |
| Nov 6, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 7,122 | n/a |
| Sep 24, 2026 | Royalty Pharma plc (RPRX) | Sale | 96,073 | $5.62M |
| Aug 19, 2026 | Royalty Pharma plc (RPRX) | Sale | 100,000 | $6.00M |
| Aug 7, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 11,002 | n/a |
| Jul 2, 2026 | Royalty Pharma plc (RPRX) | Sale | 97,446 | $5.51M |
| Jun 25, 2026 | Royalty Pharma plc (RPRX) | Sale | 32,408 | $1.75M |
| May 8, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 24,263 | n/a |
| Apr 20, 2026 | Kailera Therapeutics, Inc. (KLRA) | Grant/Award | 38,300 | n/a |
| Mar 9, 2026 | Vera Therapeutics, Inc. (VERA) | Grant/Award | 24,937 | n/a |